The B cell in atherosclerosis: teaming up with the bad guys?
Nilsson
Jan
J
Department of Clinical Sciences, Skane University Hospital in Malmö, Lund University, Malmö, Sweden. jan.nilsson@med.lu.se
Fredrikson
Gunilla Nordin
GN
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D057134:Antibodies, Neutralizing / Q000494:pharmacology; D018951:Antigens, CD20 / Q000276:immunology; D001057:Apolipoproteins E / Q000172:deficiency; D050197:Atherosclerosis / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D015551:Autoimmunity; D001402:B-Lymphocytes / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000378:metabolism; D007371:Interferon-gamma / Q000096:biosynthesis; D020381:Interleukin-17 / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D051379:Mice; D011973:Receptors, LDL / Q000172:deficiency; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D000911:Antibodies, Monoclonal; D057134:Antibodies, Neutralizing; D018951:Antigens, CD20; D001057:Apolipoproteins E; D020381:Interleukin-17; D011973:Receptors, LDL; D007371:Interferon-gamma